The amylin drug's weight results came with blood sugar numbers that analysts called disappointing, per the report.
Recap by typeshit. Post by Facebook on Facebook.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
Some women are crediting GLP-1 drugs with new chances at pregnancy. KATV cites a WHO figure that one in six people face infertility in their lifetime.
Drugs may be considered for ages 10 to 19 only after supervised programs fail. WHO says GLP-1 evidence in children is still too thin.
Loading…